In A Nutshell Fact-checks that repeat scary disease warnings while debunking false cures can accidentally make people trust ...
As the pace of change accelerates in early 2026, technical decision-makers are faced with a fundamental choice between ...
Why Anfield’s Emotional Transition Remains UnfinishedLiverpool’s transition from the Jürgen Klopp era was always destined to ...
This puzzle is known as the problem of time, and it remains one of the most persistent obstacles to a unified theory of ...
Q4 2025 Earnings Call February 11, 2026 7:30 AM ESTCompany ParticipantsCiaran Potts - Head of Investor RelationsAnthony P. J.
Over the past four decades, rare disease drug development has evolved from a scientific aspiration into a central pillar of biopharmaceutical innovation. Regulatory reforms, scientific breakthroughs, ...
On the 3rd February 2026, the Supreme Court Collegium approved the appointment of retired judges as ad hoc judges to the ...
In a significant move bridging traditional Japanese craftsmanship with Southeast Asian deep-tech innovation, Dr. Kengo Suzuki, President of Tsunan Sake Brewery (Headquarters: Tsunan, Niigata) and CEO ...
With regard to Anavex 3-71, we will be advancing Anavex 3-71 towards pivotal clinical studies for the treatment of schizophrenia-related disorders. And now I would like to direct the call to Sandra ...